Table 2.

Contrast-enhanced ultrasound (CEUS) perfusion index for individual patients at baseline, after bevacizumab, and after SBRT.

Patient	Baseline (T1)	Post bevacizumab (T2)	Post SBRT (T3)	% change (T1-T2)	% change (T2-T3)
1	0.160	0.090	0.070	−46%	−14%
2	0.070	0.004	0.001	−95%	−79%
3	0.060	0.008	0.005	−86%	−41%
4	0.007	0.001	0.001	−82%	−2%
Median change				−84%	−28%